THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY

THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY

Interferons (IFN) belong to key cytokine? of innate and adaptive immune response and play an important role in anti-viral and anti-tumor protection. At the same time, they possess a pronounced immune-modulating, anti-proliferative and anti-fibrotic effect. A general comparative characteristic of hum...

Full description

Bibliographic Details
Main Authors:	T. P. Ospelnikova, E. M. Noseikina, L. A. Gaiderova, F. I. Ershov
Format:	Article
Language:	Russian
Published:	Central Research Institute for Epidemiology 2016-10-01
Series:	Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:	influenza chronic hepatitis herpes virus infection interferons ifna therapy
Online Access:	https://microbiol.elpub.ru/jour/article/view/94

Similar Items

Altered interferon defense in children with dynamically changed infectious mononucleosis
by: E. A. Kukushkina, et al.
Published: (2021-02-01)

Combining PD-1/PD-L1 blockade with type I interferon in cancer therapy
by: Ali Razaghi, et al.
Published: (2023-08-01)

Plasma Type I IFN Protein Concentrations in Human Tuberculosis
by: Alba Llibre, et al.
Published: (2019-08-01)

HIỆU QUẢ CỦA BÀO TỬ BACILLUS SUBTILIS BIỂU HIỆN INTERFERON ALPHA GÀ TRONG PHÒNG BỆNH GUMBORO TRÊN GÀ
by: Hồ Thị Việt Thu
Published: (2012-05-01)

A Transcriptome Array-Based Approach Links Proteinuria and Distinct Molecular Signatures to Intrarenal Expression of Type I Interferon <i>IFNA5</i> in Lupus Nephritis
by: Peter Korsten, et al.
Published: (2023-06-01)

Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections
by: Aleksandr Ianevski, et al.
Published: (2021-12-01)

HIỆU QUẢ CỦA BÀO TỬ BACILLUS SUBTILIS BIỂU HIỆN INTERFERON ALPHA GÀ (B. SUBTILIS-CHIFN?) TRONG PHÒNG BỆNH NEWCASTLE TRÊN GÀ
by: Hồ Thị Việt Thu
Published: (2012-05-01)

Tolerance and Efficacy of Interferon-alpha in Hemodialysis Patients in Tripoli
by: Buargub Mahdia, et al.
Published: (2006-01-01)

Antagonism of interferon signaling by fibroblast growth factors promotes viral replication
by: Luigi Maddaluno, et al.
Published: (2020-09-01)

Imidazoquinolines with improved pharmacokinetic properties induce a high IFNα to TNFα ratio in vitro and in vivo
by: Manuel Keppler, et al.
Published: (2023-06-01)

Interferon inhibits the release of herpes simplex virus-1 from the axons of sensory neurons
by: Kevin Danastas, et al.
Published: (2023-10-01)

mSphere of Influence: Interferon Ultra Is a Means To Fight Viral Disease
by: Connor G. G. Bamford
Published: (2020-04-01)

The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections
by: Alexey A. Lozhkov, et al.
Published: (2020-11-01)

Interferon alpha, gamma, and lambda 2: are they possible culprits in the association between psoriasis and hepatitis C virus?
by: Randa Youssef, et al.
Published: (2019-01-01)

The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inhibitors
by: M G Romantsov, et al.
Published: (2014-01-01)

Cyclopheron administration in chronic pyelonephritis: changes in interferon status
by: Irina Petrovna Kudryashova, et al.
Published: (2011-06-01)

The ESCRT-Related ATPase Vps4 Is Modulated by Interferon during Herpes Simplex Virus 1 Infection
by: Jorge Ruben Cabrera, et al.
Published: (2019-04-01)

Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha
by: Lan-Juan Zhao, et al.
Published: (2016-11-01)

Respiratory infections of combined etiology in the clinical practice of the pediatrician
by: Svetlana V. Nikolaeva, et al.
Published: (2021-03-01)

Herpes Simplex Virus Type 1 Interactions with the Interferon System
by: Kevin Danastas, et al.
Published: (2020-07-01)

De novo Cryoglobulinaemic Mononeuritis Multiplex during Treatment of Chronic Hepatitis C Infection: A Viral Effect or Induced by Pegylated Interferon Alpha
by: J.R. Potts, et al.
Published: (2012-03-01)

The Innate Immune Response to Herpes Simplex Virus 1 Infection Is Dampened in the Newborn Brain and Can Be Modulated by Exogenous Interferon Beta To Improve Survival
by: Daniel Giraldo, et al.
Published: (2020-06-01)

Interferon lambda restricts herpes simplex virus skin disease by suppressing neutrophil-mediated pathology
by: Drake T. Philip, et al.
Published: (2024-04-01)

Viral encephalitis
by: Marcus Tulius T Silva
Published: (2013-09-01)

Virus B e interferón
by: Gerardo Avendaño-Alvarado
Published: (2008-11-01)

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
by: Pil Soo Sung, et al.
Published: (2018-09-01)

Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies
by: Laura A. Novotny, et al.
Published: (2021-06-01)

Interferons and hepatitis C virus
by: Markus H. Heim
Published: (2012-05-01)

Microglia Reduce Herpes Simplex Virus 1 Lethality of Mice with Decreased T Cell and Interferon Responses in Brains
by: Meng-Shan Tsai, et al.
Published: (2021-11-01)

THEORETICAL AND APPLIED ASPECTS OF THE INTERFERON SYSTEM: TO THE 60TH ANNIVERSARY OF THE DISCOVERY OF INTERFERONS
by: F. I. Ershov, et al.
Published: (2018-02-01)

PEG-INTERFERON ALPHA-2A AND LOW-DOSE RIBAVIRIN FOR TREATMENT OF HEPATITIS C VIRUS INFECTION IN PATIENTS WITH SICKLE CELL ANEMIA IN SAUDI ARABIA.
by: Adnan Agha
Published: (2014-08-01)

Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
by: Hawraa Shwaylia, et al.
Published: (2021-06-01)

A Comparison of Interferon-Alpha-2b Induction Therapy with Interferon-Alpha-2b Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
by: Bilgehan AYGEN, et al.
Published: (2004-09-01)

<FONT FACE=Symbol>a</FONT>-Interferon therapy for HBV-related glomerulonephritis
by: Edmundo Pessoa de Almeida Lopes Neto, et al.

The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses
by: Manutea C Serrero, et al.
Published: (2022-04-01)

Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Edmundo P.A. Lopes, et al.

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3
by: Aline Gonzalez Vigani, et al.

Interferon Lambda Genetics and Biology in Regulation of Viral Control
by: Emily A. Hemann, et al.
Published: (2017-12-01)

Effect of Pegylated Interferon on Non-Responders and Relapsers with Interferon
by: Hisham O. Akbar, et al.
Published: (2002-04-01)

Antiviral/immunomodulatory combination therapy: Pegylated interferon alpha 2a and ribavirin in patients with chronic hepatitis C virus infection
by: Delić Dragan, et al.
Published: (2012-01-01)